Skip to main content

Acne Scars

3
Pipeline Programs
3
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
2 programs
1
1
Restylane Vital LidocainePhase 41 trial
AdapalenePhase 21 trial
Active Trials
NCT01213199Completed20Est. Sep 2012
NCT01807455Completed12Est. Dec 2014
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
ELAPR002fPhase 33 trials
Active Trials
NCT07207369Recruiting395Est. Nov 2029
NCT06151535Completed30Est. Feb 2025
NCT05995340Active Not Recruiting157Est. Jul 2026
Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
1 program
Picosecond 755nm Alexandrite LaserN/A1 trial
Active Trials
NCT05579171Unknown20Est. Oct 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
GaldermaRestylane Vital Lidocaine
AbbVieELAPR002f
AbbVieELAPR002f
AbbVieELAPR002f
GaldermaAdapalene
Fitzpatrick CompanyPicosecond 755nm Alexandrite Laser

Clinical Trials (6)

Total enrollment: 634 patients across 6 trials

NCT01807455GaldermaRestylane Vital Lidocaine

An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine

Start: Apr 2013Est. completion: Dec 201412 patients
Phase 4Completed
NCT07207369AbbVieELAPR002f

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

Start: Oct 2025Est. completion: Nov 2029395 patients
Phase 3Recruiting
NCT05995340AbbVieELAPR002f

ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars

Start: Nov 2023Est. completion: Jul 2026157 patients
Phase 3Active Not Recruiting
NCT06151535AbbVieELAPR002f

A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quality in Adult Participants

Start: Dec 2023Est. completion: Feb 202530 patients
Phase 2Completed
NCT01213199GaldermaAdapalene

Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

Start: Mar 2011Est. completion: Sep 201220 patients
Phase 2Completed
NCT05579171Fitzpatrick CompanyPicosecond 755nm Alexandrite Laser

Lasers to Aid in Treatment of Acne Scars

Start: Nov 2022Est. completion: Oct 202320 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 634 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.